Fierce Biotech
About Fierce Biotech
Fierce Biotech is a leading biopharmaceutical news and analysis site that delivers timely, practical coverage of the drug development industry. Our mission is to inform and equip biopharma professionals by tracking regulatory approvals, clinical data, manufacturing, commercialization, payer dynamics, patent and legal developments, mergers & acquisitions, and other forces shaping the sector. We aim to explain not just what happened, but why it matters to companies, investors, clinicians and other stakeholders.
What we cover
We provide daily news, in-depth analysis and special reports across the full biopharma lifecycle, helping readers stay current on breakthroughs, industry trends and business implications. Typical coverage includes:
- Drug development and clinical trial results
- Regulatory policy and approvals
- Commercial strategy, pricing and payer negotiations
- Mergers, partnerships and financing activity
- Manufacturing, supply chain and emerging technologies (e.g., cell & gene therapy, biologics)
Our approach and reach
As part of Questex’s healthcare and life sciences portfolio, Fierce Biotech combines newsroom expertise with data-driven reporting to surface the most relevant stories for decision-makers in biotech, pharma and related fields. We publish daily content and special reports to help readers anticipate risks and opportunities in a fast-moving industry.